Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7199566 | 1.00 | MAPK1 (0.53) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL6248372 | 1.00 | MAPK1 (0.53) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL1615850 | 1.00 | MAPK1 (0.53) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL27922653 | 1.00 | MAPK1 (0.53) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL3171 | 0.98 | MAPK1 (0.54) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL20303983 | 0.98 | MAPK1 (0.54) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL7305358 | 0.98 | MAPK1 (0.54) | MAPK1KDM4EHSD17B10MCL1KMT2A | |
| SCHEMBL25061 | 0.92 | MAPK1 (0.47) | MAPK1KDM4EHSD17B10MCL1CA1 | |
| SCHEMBL31276435 | 0.92 | MAPK1 (0.47) | MAPK1KDM4EHSD17B10MCL1CA1 | |
| SCHEMBL374935 | 0.92 | MAPK1 (0.47) | MAPK1KDM4EHSD17B10MCL1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400792-A1 | CURABLE (METH)ACRYLATE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2024-12-05 | — | — | US | claimed |
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | claimed |
| US-20240392094-A1 | Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition | LG CHEM, LTD. (KR) | 2024-11-28 | — | — | US | claimed |
| CN-118355086-A | Curable (meth) acrylate composition | 汉高股份有限及两合公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117897440-A | Method for screening solvent for extraction of polyvinyl chloride, method for recycling waste material, recycled polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | claimed |
| CN-117897439-A | Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | claimed |
| WO-2023104819-A1 | CURABLE (METH) ACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2023-06-15 | — | — | WO | claimed |
| WO-2023033605-A1 | METHOD FOR SCREENING SOLVENT FOR EXTRACTING POLYVINYL CHLORIDE, METHOD FOR RECYCLING WASTE, RECYCLED POLYVINYL CHLORIDE, AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| WO-2023033601-A1 | METHOD FOR SCREENING SOLVENT FOR POLYVINYL CHLORIDE EXTRACTION, RECYCLING METHOD FOR WASTE MATERIAL, AND RECYCLED POLYVINYL CHLORIDE AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| US-20240400792-A1 | CURABLE (METH)ACRYLATE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2024-12-05 | — | — | US | disclosed |
| US-20240392094-A1 | Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition | LG CHEM, LTD. (KR) | 2024-11-28 | — | — | US | disclosed |
| US-20240342295-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | THE UNIVERSITY OF MANCHESTER (GB) | 2024-10-17 | — | — | US | disclosed |
| CN-118355086-A | Curable (meth) acrylate composition | 汉高股份有限及两合公司 | 2024-07-16 | — | — | CN | disclosed |
| US-6921776-B1 | Compound | STERIX LIMITED (GB) | 2005-07-26 | — | — | US | disclosed |
| US-20050154050-A1 | Compound | REED MICHAEL J (GB) | 2005-07-14 | — | — | US | disclosed |
| EP-0610439-B1 | PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS | AMERICAN HOME PROD (US) | 1999-12-15 | — | — | EP | disclosed |
| EP-0610439-A1 | PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-08-17 | — | — | EP | disclosed |
| US-5234936-A | Treating hypertension, congestive heart failure, hyperlipidemia and hypercholesterolemia | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-08-10 | — | — | US | disclosed |
| WO-1993008171-A1 | PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154050-A1 | Compound | HSD17B11, NR5A1, CYP17A1 | MAPK1 4081/4885KDM4E 1129/4885HSD17B10 24/4885 |
| US-20240342295-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | CHRM2, CMBL, H1-0 | MAPK1 1745/4885KDM4E 987/4885HSD17B10 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.